U.S. - Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPenicillins Or Streptomycins Medicaments Prices in the United States
U.S. Penicillins Or Streptomycins Medicaments Import Price per Ton in August 2022
In August 2022, the penicillins or streptomycins medicaments price per ton amounted to $48.9K (CIF, US), with a decrease of -35% against the previous month. Overall, the import price recorded a abrupt contraction. The most prominent rate of growth was recorded in April 2022 an increase of 43% m-o-m. As a result, import price attained the peak level of $97.0K per ton. From May 2022 to August 2022, the average import prices failed to regain momentum.
Prices varied noticeably by the country of origin: the country with the highest price was India ($70.2K per ton), while the price for Slovenia ($27.8K per ton) was amongst the lowest.
From January 2022 to August 2022, the most notable rate of growth in terms of prices was attained by Jordan (+3.2%), while the prices for the other major suppliers experienced more modest paces of growth.
U.S. Penicillins Or Streptomycins Medicaments Imports
Penicillins or streptomycins medicaments imports into the United States skyrocketed to 687 tons in August 2022, surging by 41% on the previous month. The total import volume increased at an average monthly rate of +2.6% over the period from January 2022 to August 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain months. As a result, imports attained the peak and are likely to continue growth in the immediate term.
In value terms, penicillins or streptomycins medicaments imports fell to $34M (IndexBox estimates) in August 2022. Overall, imports, however, showed a abrupt curtailment. The most prominent rate of growth was recorded in July 2022 with an increase of 39% against the previous month.
U.S. Penicillins Or Streptomycins Medicaments Imports by Country
China (141 tons), Italy (137 tons) and India (133 tons) were the main suppliers of penicillins or streptomycins medicaments imports to the United States, with a combined 60% share of total imports.
From January 2022 to August 2022, the biggest increases were in China (with a CAGR of +18.0%), while purchases for the other leaders experienced more modest paces of growth.
In value terms, the largest penicillins or streptomycins medicaments suppliers to the United States were India ($9.4M), Italy ($8.2M) and Austria ($5.1M), with a combined 68% share of total imports.
In terms of the main suppliers, Italy, with a CAGR of +8.5%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced mixed trend patterns.
This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201160 - Medicaments of penicillins, streptomycins or derivatives thereof, in doses or p.r.s.
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET STRUCTURE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- TRADE BALANCE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORTS
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Market Size and Growth, By Product
- Average Per Capita Consumption, By Product
- Exports and Growth, By Product
- Export Prices and Growth, By Product
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
326
This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in the U.S..
314
This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in the U.S..
331
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..
305
This report provides an in-depth analysis of the medicaments containing vitamins market in the U.S..
399
This report provides an in-depth analysis of the global market for penicillins or streptomycins medicaments.
415
This report provides an in-depth analysis of the global market for medicaments containing corticosteroid hormones.
392
This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.
545
This report provides an in-depth analysis of the global medicaments containing vitamins market.
326
This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in the U.S..
314
This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in the U.S..
180
Eli Lilly is strategizing to increase Zepbound sales as they face supply chain difficulties, impacting their revenue outlook.
205
The FDA has approved Novo Nordisk's Ozempic for chronic kidney disease, extending its use beyond Type 2 diabetes. This approval marks a significant advancement in managing related health conditions.
115
Discover how Medicare's new price negotiations for popular weight loss drugs like Ozempic and Wegovy aim to reduce costs and impact global pharmaceutical trade.
285
Discover how Eli Lilly's Zepbound received Medicare coverage for sleep apnea, offering new treatment possibilities for millions of Americans.
244
Explore the top import markets for penicillins and streptomycins medicaments based on data from the IndexBox market intelligence platform.
21
Global market for corticosteroid hormone medicaments reached 347K tons ($71.9B) in 2024. Forecasted to grow at 1.7% CAGR to 418K tons by 2035, with market value reaching $101B. Denmark leads consumption and production.
21
Global corticosteroid market to grow at a CAGR of +1.7% in volume and +3.1% in value, reaching 418K tons and $101B by 2035. Driven by rising global demand for these medicaments.
378
Discover the top import markets for medicaments containing corticosteroid hormones. Read about the import values and key statistics of the leading countries including the United States, Switzerland, China, and more.
200
Explore the top import markets for prophylactic medicaments containing insulin, including key statistics and import values. Learn about the leading countries driving the demand for these essential healthcare products.
301
Mitsubishi Chemical selects Bain Capital for Tanabe Mitsubishi Pharma acquisition in a deal surpassing $3.2 billion, aiming to streamline operations.
